Skip to main content
OpenTrials
Completed

NCT Number: NCT01125371

Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women

African American (AA) women are disproportionately affected by HIV/AIDs. The major risk factor for HIV acquisition among AA women is high-risk heterosexual sex, including unprotected vaginal and anal sex, and sex with a high-risk partner. Hazardous alcohol use has been associated with high risk sexual behaviors and prevalent gonorrhea among women attending an urban STI clinic, both of which increase a woman's vulnerability to HIV acquisition and transmission. This application proposes a randomized controlled trial (RCT) of a culturally tailored computer-directed brief alcohol intervention (CBI) enhanced with cell-phone booster calls using interactive voice response technology (IVR) and text messages among HIV-infected and at-risk AA women attending an urban STI Clinic. Hazardous drinking AA women (N=450) presenting with STI complaints will be randomized to one of three arms: 1) usual clinical care, 2) clinic-based, CBI, or 3) clinic-based, CBI + 3 booster calls using IVR and text messages. The CBI, an evidence-based based method for behavior change, will use principles of motivational interviewing, to counsel on: 1) alcohol use and 2) associated HIV/STI risk behaviors. Primary outcomes, measured at 3, 6, and 12 month intervals, include alcohol-related risk behaviors (number of binge drinking episodes, drinking days/week, and drinks per occasion), sexual risk behaviors (number of partners, episodes of unprotected vaginal/anal sex, episodes of sex while high), and occurrence of HIV/STI biomarkers. Prior to implementing the RCT, the CBI and IVR software messages will be revised to: 1) include the association between hazardous alcohol use and risky sexual behaviors, and 2) ensure their relevance and acceptability using quantitative/qualitative feedback from a sample of AA women attending a Baltimore City STI clinic. The proposed research focuses on a particularly vulnerable population of urban HIV at-risk and HIV-infected AA women seeking treatment in a public STI clinic and examines two novel BI intervention delivery strategies specifically tailored to be culturally/socially relevant to this minority population. If the intervention(s) prove to be effective, study findings will offer "real life" specialty care clinics a screening and intervention package that is practical, low cost, and easy to implement.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older;
  • HIV infected or HIV negative and attending the Baltimore City Health Department sexually transmitted infection clinic for STI-related services
  • Consumes an average of 8 or more drinks per week OR has had two binge drinking episodes (4 drinks/occasion) in the last 3 months
  • sexually active
  • Cognitively able to understand proposed research design (10 min screening, followed by random assignment to one of three study groups (if individual fulfills criteria for RCT enrollment);
  • Able to speak and understand English
  • Able and willing to receive text messages

Exclusion criteria

  • Pregnant women will be excluded and referred directly to social work for referral to either alcohol or drug treatment due to ethical concerns of randomization to usual care.
  • Currently enrolled in alcohol or drug treatment.
  • Non-English Speaking.
  • Actively Psychotic or have other severe mental health symptoms that would prevent appropriate participation in the brief intervention protocol.
  • Planning on moving out of the area within 12 months of study entry

Treatment and study plan

Computerized brief alcohol intervention + IVR booster calls

Behavioral
  • Computerized brief alcohol intervention + IVR booster calls: Clinic-based computerized brief alcohol intervention (delivered once) followed by three booster phone calls using interactive voice response technology + text messages

Other names: CBI+IVR+TM

Computerized brief alcohol intervention

Behavioral

Computerized brief alcohol intervention: Clinic based computer delivered brief alcohol intervention delivered one time

Other names: CBI

Attention Control

Behavioral

Attention Control: 20 minute attention control condition focused on dental hygiene delivered once

Primary outcomes

  1. Change in Alcohol Use (Heavy Drinking Days)

    Time frame: Baseline, 3, 6, and 12 months

    Change in alcohol-related risk behavior as assessed by the number of heavy drinking days.

  2. Change in Alcohol Use (Drinking Days)

    Time frame: Baseline, 3, 6, and 12 months

    Change in alcohol-related risk behavior as assessed by the number of drinking days.

  3. Change in Alcohol Use (Drinks Per Drinking Day)

    Time frame: Baseline, 3, 6, and 12 months

    Change in alcohol-related risk behavior as assessed by the standard drinks per drinking day.

  4. Change in Alcohol Use (Drinks Per Week)

    Time frame: Baseline, 3, 6, and 12 months

    Change in alcohol-related risk behavior as assessed by the standard drinks per week.

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Registry information

Official study title

Computerized BI for Binge Drinking HIV At-Risk and Infected African-American Women

Important dates

Study start
2011
Primary completion
2016
Study completion
2016
First posted
May 18, 2010
Registry last updated
Jun 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.